Wall Street Zen Downgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold

Key Points

• Wall Street Zen has downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating, indicating a shift in analysts' sentiment towards the stock.
• Several brokerages, including Barrington Research and Wells Fargo, have also decreased their target prices for DENTSPLY SIRONA, reflecting concerns about its performance.
• DENTSPLY SIRONA reported a quarterly EPS of $0.52, exceeding analyst estimates, but its revenue declined by 4.9% compared to the prior year, signaling potential trouble ahead.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) was downgraded by analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a note issued to investors on Saturday.

A number of other brokerages also recently commented on XRAY. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating for the company in a research note on Wednesday, October 8th. Weiss Ratings restated a "sell (d-)" rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Finally, UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Two research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $18.00.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $12.51 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The firm has a fifty day moving average price of $13.38 and a 200 day moving average price of $14.52. The company has a market cap of $2.50 billion, a P/E ratio of -2.64, a PEG ratio of 0.79 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $11.69 and a 12 month high of $24.86.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company's revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds have recently made changes to their positions in the business. CWM LLC boosted its stake in shares of DENTSPLY SIRONA by 84.3% during the third quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier's stock worth $5,336,000 after buying an additional 192,373 shares during the period. World Investment Advisors acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth about $888,000. Parcion Private Wealth LLC acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth about $212,000. Brighton Jones LLC boosted its stake in shares of DENTSPLY SIRONA by 15.6% during the third quarter. Brighton Jones LLC now owns 71,260 shares of the medical instruments supplier's stock worth $904,000 after buying an additional 9,623 shares during the period. Finally, Sound Income Strategies LLC boosted its stake in shares of DENTSPLY SIRONA by 26.2% during the third quarter. Sound Income Strategies LLC now owns 461,924 shares of the medical instruments supplier's stock worth $5,645,000 after buying an additional 95,980 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.